TTF-1 Antibodies
Target-specific antibody reagent for assay development, optimization and analytical evaluation involving TTF-1. Nuclear IHC target supporting pulmonary adenocarcinoma and thyroid differentiation in pathology panels.
Product Type
Antibodies & Antigens
Sub-Category
Analyte Antibodies
Platform
IHC
Application
END, ONC
Overview
Target-specific antibody reagent for assay development, optimization and analytical evaluation involving TTF-1. Nuclear IHC target supporting pulmonary adenocarcinoma and thyroid differentiation in pathology panels.
Target-specific antibody reagent for assay development, optimization and analytical evaluation involving TTF-1. Nuclear IHC target supporting pulmonary adenocarcinoma and thyroid differentiation in pathology panels. TTF-1/NKX2-1 is widely used in lung and thyroid pathology. In lung carcinoma, TTF-1 and Napsin A are complementary markers for adenocarcinoma differentiation, but neither is absolutely site specific.
Professional Context
TTF-1/NKX2-1 is widely used in lung and thyroid pathology. In lung carcinoma, TTF-1 and Napsin A are complementary markers for adenocarcinoma differentiation, but neither is absolutely site specific.
Technical Specifications
Antibody Information
| Parameter | Specification |
|---|---|
| Target | TTF-1 |
| Technology Platform | Immunohistochemistry |
| Application Tags | END;ONC |
| Storage | -25~ -10℃ |
| Shelf Life | 4年 |
| Sample Pack | 0.1mL |
Target
TTF-1
Technology Platform
Immunohistochemistry
Application Tags
END;ONC
Storage
-25~ -10℃
Shelf Life
4年
Sample Pack
0.1mL
Technical Resources
Product datasheets, quality certificates and related technical documentation are available upon request from our technical team.
Need to confirm the right product or material for your project?
Our technical team can assist with product selection, provide samples, and support your IVD development project.